Compare KRT & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRT | MNPR |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 492.5M | 531.6M |
| IPO Year | 2021 | 2019 |
| Metric | KRT | MNPR |
|---|---|---|
| Price | $22.37 | $76.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 13 |
| Target Price | $29.67 | ★ $97.83 |
| AVG Volume (30 Days) | 128.8K | ★ 158.9K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | ★ 8.19% | N/A |
| EPS Growth | ★ 6.32 | N/A |
| EPS | ★ 1.50 | N/A |
| Revenue | ★ $453,775,000.00 | N/A |
| Revenue This Year | $11.29 | N/A |
| Revenue Next Year | $11.05 | N/A |
| P/E Ratio | $14.66 | ★ N/A |
| Revenue Growth | ★ 8.93 | N/A |
| 52 Week Low | $20.61 | $21.00 |
| 52 Week High | $33.89 | $105.00 |
| Indicator | KRT | MNPR |
|---|---|---|
| Relative Strength Index (RSI) | 51.09 | 42.35 |
| Support Level | $21.60 | $74.51 |
| Resistance Level | $22.52 | $85.01 |
| Average True Range (ATR) | 0.57 | 6.84 |
| MACD | 0.15 | -1.16 |
| Stochastic Oscillator | 97.90 | 7.38 |
Karat Packaging Inc is engaged in the manufacturing and distribution of disposable products used in restaurants and food service settings. The company operates and evaluates its business as a single reportable segment which encompasses the manufacturing and distribution of a diverse range of single-use food and beverage service products made from materials such as plastic, paper, biopolymer-based, and other compostable forms. The company offers products for the foodservice industry, including food packaging, containers, tableware, cups, lids, cutlery, and straws. These products are available in plastic, paper, biopolymer-based and other compostable forms. Its product line includes a variety of brands such as Tea Zone, Karat, Karat Earth, and Total Clean.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.